184 related articles for article (PubMed ID: 17049687)
1. Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003.
Kabir S
Vaccine; 2007 Feb; 25(8):1353-4. PubMed ID: 17049687
[No Abstract] [Full Text] [Related]
2. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.
Anh DD; Canh DG; Lopez AL; Thiem VD; Long PT; Son NH; Deen J; von Seidlein L; Carbis R; Han SH; Shin SH; Attridge S; Holmgren J; Clemens J
Vaccine; 2007 Jan; 25(6):1149-55. PubMed ID: 17055622
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F
Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.
Raghava Mohan V; Raj S; Dhingra MS; Aloysia D'Cor N; Singh AP; Saluja T; Kim DR; Midde VJ; Kim Y; Vemula S; Narla SK; Sah B; Ali M
PLoS One; 2019; 14(6):e0218033. PubMed ID: 31211792
[TBL] [Abstract][Full Text] [Related]
6. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
7. Vibrio cholerae: lessons for mucosal vaccine design.
Bishop AL; Camilli A
Expert Rev Vaccines; 2011 Jan; 10(1):79-94. PubMed ID: 21162623
[TBL] [Abstract][Full Text] [Related]
8. A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia.
Desai SN; Akalu Z; Teshome S; Teferi M; Yamuah L; Kim DR; Yang JS; Hussein J; Park JY; Jang MS; Mesganaw C; Taye H; Beyene D; Bedru A; Singh AP; Wierzba TF; Aseffa A
Am J Trop Med Hyg; 2015 Sep; 93(3):527-533. PubMed ID: 26078323
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.
Charles RC; Hilaire IJ; Mayo-Smith LM; Teng JE; Jerome JG; Franke MF; Saha A; Yu Y; Kováč P; Calderwood SB; Ryan ET; LaRocque RC; Almazor CP; Qadri F; Ivers LC; Harris JB
PLoS Negl Trop Dis; 2014 May; 8(5):e2828. PubMed ID: 24786645
[TBL] [Abstract][Full Text] [Related]
10. [Cholera vaccine].
Ehara M
Nihon Rinsho; 2005 May; 63 Suppl 5():625-30. PubMed ID: 15954420
[No Abstract] [Full Text] [Related]
11. Cholera vaccine: new preventive tool for endemic countries.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2012 May; 8(5):682-4. PubMed ID: 22634452
[TBL] [Abstract][Full Text] [Related]
12. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
[TBL] [Abstract][Full Text] [Related]
13. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
[TBL] [Abstract][Full Text] [Related]
14. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers.
Pitisuttithum P; Migasena S; Suntharasamai P; Supanaranond W; Desakorn V; Prayurahong B
Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):201-5. PubMed ID: 2609209
[TBL] [Abstract][Full Text] [Related]
15. Response to "questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003" Vaccine 2007;25(8):1353-4.
Thiem VD; Canh DG; Anh DD; Deen JL; von Seidlein L; Clemens JD; Holmgren J
Vaccine; 2007 Nov; 25(47):7981-3. PubMed ID: 17933443
[No Abstract] [Full Text] [Related]
16. Oral vaccines against cholera: lessons from Vietnam and elsewhere.
Levine MM
Lancet; 1997 Jan; 349(9047):220-1. PubMed ID: 9014902
[TBL] [Abstract][Full Text] [Related]
17. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.
Capeding MRZ; Gonzales MLAM; Dhingra MS; D'Cor NA; Midde VJ; Patnaik BN; Thollot Y; Desauziers E
Hum Vaccin Immunother; 2017 Oct; 13(10):2232-2239. PubMed ID: 28910563
[TBL] [Abstract][Full Text] [Related]
19. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
[TBL] [Abstract][Full Text] [Related]
20. [Dukoral, oral cholera vaccine].
Ragot C; Garnotel E; Vedy S; Morillon M
Med Trop (Mars); 2006 Jun; 66(3):237-9. PubMed ID: 16924813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
